Ignite Creation Date:
2024-05-06 @ 11:09 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03441516
Status:
UNKNOWN
Last Update Posted:
2020-12-22
First Post:
2018-02-05
Brief Title:
Effect of Choline Alphoscerate on Cognitive Function in Alzheimers Dementia
Sponsor:
Yuhan Corporation
Organization:
Yuhan Corporation
Study Overview
Official Title:
Effect of Choline Alphoscerate on Cognitive Function in Alzheimers Dementia A Multi-center Randomized Open-label Pilot Study
Status:
UNKNOWN
Status Verified Date:
2020-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ALFO-AD
Brief Summary:
This study will evaluate the performance of Alzheimers Disease Assessment Scale-cognitive subscale ADAS-cog in patients with Alzheimers disease AD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None